The emergence of Retatrutide ZPHC, at a concentration of 120mg, is creating considerable buzz within the weight loss community. This groundbreaking dual GIP and GLP-1 agonist medication seems to offer notable improvements in fat loss compared to previous therapies. Preliminary clinical trials have shown substantial decreases in weight , conceivably